This week’s episode looks at some of the major developments in the Alzheimer’s drug space and how it’s impacting corporate activity. Joining host Julie-Anna Needham is Dane Hamilton, healthcare editor for Acuris. Dealcast is presented by Mergermarket and SS&C Intralinks.
Related Links:
<ul>
<li><a href="https://www.intralinks.com" rel="nofollow noreferrer noopener" target="_blank">https://www.intralinks.com</a></li>
</ul>

This week’s episode looks at some of the major developments in the Alzheimer’s drug space and how it’s impacting corporate activity. Joining host Julie-Anna Needham is Dane Hamilton, healthcare editor for Acuris. Dealcast is presented by Mergermarket and SS&C Intralinks. Related Links: https://www.intralinks.com

This week’s episode looks at some of the major developments in the Alzheimer’s drug space and how it’s impacting corporate activity. Joining host Julie-Anna Needham is Dane Hamilton, healthcare editor for Acuris. Dealcast is presented by Mergermarket and SS&amp;C Intralinks.
Related Links:
<ul>
<li><a href="https://www.intralinks.com" rel="noopener noreferrer">https://www.intralinks.com</a></li>
</ul>

Developments in the Alzheimer’s drug space and investments into Healthtech

This podcast gives dealmakers perspectives on mergers and acquisitions (M&A) trends, the biggest deals and insight into the latest technology news and trends. Listen to learn about best practices from deal professionals and industry thought leaders.

Business

Technology

This podcast gives dealmakers perspectives on mergers and acquisitions (M&amp;A) trends, the biggest deals and insight into the latest technology news and trends. Listen to learn about best practices from deal professionals and industry thought leaders.

Share Developments in the Alzheimer’s drug space and investments into Healthtech

Sign up to save your podcasts

Developments in the Alzheimer’s drug space and investments into Healthtech

Developments in the Alzheimer’s drug space and investments into Healthtech